One of the roles of The Western Australian Kirkbride Melanoma Advisory Service is to participate in melanoma research with the aim of improving the outlook for melanoma patients both now and in the future. An important part of any clinical research may involve collecting medical information on a patient in the future or following their initial treatment. All data used by researchers is de-identified to protect patient privacy and research studies conducted using the WAKMAS data is subject to approval from the ethics committee.
|Melanoma: A new strategy to reduce morbidity and mortality||Cameron Williams, Christopher Quirk, Anna Quirk Austin Hospital, Melbourne, Australia||Download|
|A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service||Linda Mohshizadeh, Mark Hanikeri, Trevor W. Beer and Peter J. Heenan||Download|
|Primary dermal melanoma: a West Australian cohort||James Teow, Olivia Chin, Mark Hanikeri and Benjamin A. Wood||Download|
|Factors affecting Breslow thickness: Results from a survey of 114 Western Australian patients with thicker melanoma||David Matthew Hille-1, Simon David Mahoney-1, Christopher John Quirk-2,3: 1-Royal Perth Hospital, Perth, 2-Dermatology Specialist Group, Ardross, and 3-Western Australia Kirkbride Melanoma Advisory Service, Nedlands, Western Australia.||Download|
|Juvenile melanomas: Western Australian Melanoma Advisory Service experience||Jie Xin Xu, Sharnice Koek, Samantha Lee, Mark Hanikeri, Mark Lee, Trevor Beer, Christobel Saunders: St John of God Hospital, Perth, Western Australia, Australia||Download|